Quest to buy Shiel Medical Lab, Updates Expected Revenue, EPS Forecast

Sep 27, 2017

|

NEW YORK (360Dx) – Quest Diagnostics today announced an agreement to buy the Shiel Medical Laboratory business from Fresenius Medical Care.

On Wednesday, Quest also said that it anticipates a 1.5 percent reduction in revenues for the third quarter, due to recent natural disasters in the US and elsewhere. The company also expects a $.10 reduction in EPS and adjusted EPS for the third quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Quest to buy Shiel Medical Lab, Updates Expected Revenue, EPS Forecast

To read the full story....

Breaking News

Somalogic Closes $121M Series A Funding

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

In Brief This Week: Quest Diagnostics, Fluidigm, BD, and More

Tempus Gets CE Mark for xT Tumor Sequencing Assay

BTIG Downgrades Fulgent Genetics from Buy to Neutral

What's Popular?

FDA Issues EUAs for Gravity Diagnostics Coronavirus Test, Sample Self-Collection Kit from RapidRona

BTIG Downgrades Fulgent Genetics from Buy to Neutral

Kantaro Biosciences Gets FDA Emergency Use Authorization for Coronavirus Antibody Test

Quest Diagnostics Enters Lab Services Agreement With Montefiore Nyack, Goshen Hospital

Abviris Developing Blood-Based Serology Test For HPV-Related Cancers

Sponsorships